Merav Bassan - Aug 22, 2022 Form 4 Insider Report for BiomX Inc. (PHGE)

Role
Chief Development Officer
Signature
/s/ Merav Bassan
Stock symbol
PHGE
Transactions as of
Aug 22, 2022
Transactions value $
$0
Form type
4
Date filed
8/24/2022, 04:01 PM
Previous filing
Mar 31, 2022
Next filing
Mar 3, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PHGE Common Stock Options - Right to Buy Award $0 +75K $0.00 75K Aug 22, 2022 Common Stock 75K $0.66 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest and become exercisable over four years, with 25% of the shares subject to the option vesting on August 22, 2023, and the remainder vesting in 12 equal quarterly installments over three years.